Vimarsana
Biggest News Aggregation in the World

Medicines Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medicines Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medicines Plus Today - Breaking & Trending Today

APO Group - Africa Newsroom / Press release | United States (U.S.) Helps Madagascar Keep Medicines Safe and Effective - Vimarsana News

APO Group - Africa Newsroom / Press release | United States (U.S.) Helps Madagascar Keep Medicines Safe and Effective

United States (U.S.) Helps Madagascar Keep Medicines Safe and Effective

SWIPHA obtains World Health Organisation product prequalification - Vimarsana News

SWIPHA obtains World Health Organisation product prequalification

Swiss Pharma Nigeria Limited (SWIPHA) has received WHO prequalification of Zinc Dispersible 20mg tablet from the World Health Organisation (WHO). | Pulse Nigeria

Source: pulse.ng
SWIPHA obtains World Health Organisation product prequalification - Vimarsana News

SWIPHA obtains World Health Organisation product prequalification

According to Frederic Lieutaud, the Managing Director of Swiss Pharma Nigeria Limited, the WHO pre-qualification is a rigorous process that evaluates pharmaceutical products based on their quality, safety, and efficacy.

SWIPHA obtains World Health Organisation product prequalification - Vimarsana News

SWIPHA obtains World Health Organisation product prequalification

In what could be described as another first among many by the company, Swiss Pharma Nigeria Limited (SWIPHA), a subsidiary of Servier, a French

COVID-19 Public Health Emergency Ends in the U.S., but Need to Ensure Access to Quality Assured Vaccines Remains - Vimarsana News

COVID-19 Public Health Emergency Ends in the U.S., but Need to Ensure Access to Quality Assured Vaccines Remains

USP builds upon COVID Learnings about Stakeholder Collaboration, Supply Chain Vulnerabilities and Quality Standards to Meet Future Vaccine Demand